Methadone maintenance therapy and HIV counseling and testing are associated with lower frequency of risky behaviors among injection drug users in China

Substance Use and Misuse

Volumn 50, Issue 1, 2015, Pages 15-23

  Wang, Mei ^a,b   Mao, Wenwen ^c   Zhang, Linglin ^b   Jiang, Baofa ^d   Xiao, Yan ^e   Jia, Yujiang ^f   Wu, Pingsheng ^a   Cassell, Holly ^a   Vermund, Sten ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sichuan Center for Disease Control and Prevention   (China)

^c Fengtai Center for Control and Prevention   (China)

^d SHANDONG UNIVERSITY   (China)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f Center for Disease Control and Prevention ^*  (United States)

Author keywords

HIV behavior; HIV prevention; HIV voluntary counseling and testing; Injection drug use; Methadone maintenance treatment; Needle sharing; Sexual risk behavior; Substance use

Indexed keywords

METHADONE;

ADOLESCENT; ADULT; CHINA; COUNSELING; CROSS-SECTIONAL STUDY; DRUG ABUSE; FEMALE; HIGH RISK BEHAVIOR; HIV INFECTIONS; HUMAN; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; PSYCHOLOGY; SERODIAGNOSIS; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; SYPHILIS; UNSAFE SEX; YOUNG ADULT;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; CHINA; COUNSELING; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; METHADONE; MIDDLE AGED; NEEDLE SHARING; OPIATE SUBSTITUTION TREATMENT; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; SYPHILIS; UNSAFE SEX; YOUNG ADULT;

EID: 84926332469     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2014.957768     Document Type: Article

References (50)

1. Asher, A. K, Hahn, J. A, Couture, M. C, Maher, K, & Page, K. (2013). People who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care, 24(6), e35-44.
2. Bao, Y. G., & Zhang, Y. H. (2007). Risk factors on heroin lapse of methadone maintenance treatment outpatients. Practical Preventive Medicine, 14(6), 1923-1925.
3. Branson, B. M., Handsfield, H. H., Lampe, M. A., Janssen, R. S., Taylor, AW, Lyss, SB, & Clark, JE.(2006). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep, 55(RR- 14), 1-17; quiz CE11-14.
4. Bruneau, J, Daniel, M, Abrahamowicz, M, Zang, G, Lamothe, F, & Vincelette, J. (2011). Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: A 16-year longitudinal study. Am J Epidemiol, 173(9), 1049-1058.
5. Carrieri, M. P., Moatti, J. P., Vlahov, D., Obadia, Y., Reynaud-Maurupt, C., & Chesney, M. (1999). Access to antiretroviral treatment among French HIV infected injection drug users: The influence of continued drug use. MANIF 2000 Study Group. J Epidemiol Community Health, 53(1), 4-8.
6. Chen, XS, Gong, XD, Liang, GJ, & Zhang, GC. (2000). Epidemiologic trends of sexually transmitted diseases in China. Sex Transm Dis, 27(3), 138-142.
7. Chen, KL, Hao, C, Yuan, YH, Xie, LZ, Wu, J, Xia, Y, . . . Qin, G. (2006). Qualitative study of factors contributed to retention in a community-based methadone maintenance treatment among heroin users. Chin J Drug Depend, 12(6), 315-319.
8. China National Narcotics Control Committee. (2011). Annual Report on Drug Control in China. Beijing.
9. Chu, T. X, & Levy, J. A. (2005). Injection drug use and HIV/AIDS transmission in China. Cell Res, 15(11-12), 865-869.
10. Cohen, MS, Chen, YQ, McCauley, M, Gamble, T, Hosseinipour, MC, Kumarasamy, N, . . . Pilotto, J. H.. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England journal of medicine, 365(6), 493-505.
11. Cohen, M. S., Ping, G., & Fox, K.. (2000). Sexually transmitted diseases in the People's Republic of China in Y2K: Back to the future. Sex Transm Dis, 27, 143-145.
12. Downing, M, Knight, K, Reiss, TH, Vernon, K, Mulia, N, Ferreboeuf, M, . . . Vu, C. (2001). Drug users talk about HIV testing: Motivating and deterring factors. AIDS Care, 13(5), 561-577.
13. Ford, K., Wirawan, D. N., Sumantera, G. M., Sawitri, A. A., & Stahre,M. (2004).Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia. AIDS Educ Prev, 16(6), 487-498.
14. Gao, Q, Cheng, H, & Ding, L. (2008). Characteristics of methadone maintenance treatment patients' social network and status of sustainment ACTA UNIVERSITIS MEDICINALIS NANJING( Social Science), 32(3), 230-233.
15. Gong, X.,Wang, Q., & Liang, G. (2001). Epidemiological trends of sexually transmitted diseases in China. Chin J STD AIDS Prev Control, 7(suppl), 46-51.
16. Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 16(2), CD004145.
17. Gowing, L., Farrell, M. F., Bornemann, R., Sullivan, L. E., Ali, R. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (8), CD004145.
18. Hao, C., Wu, J., Ruan, Y., Yao, M., Yang, X., Li, L., . . . Song l. (2007). Factors associated with retention in a community-based methadone maintenance treatment among heroin addicts. Chin J Prev Med, 41(4), 250-253.
19. Jia, Y., Lu, F., Sun, X.,&Vermund, S. H. (2007). Sources of data for improved surveillance of HIV/AIDS in China. Southeast Asian J Trop Med Public Health, 38(6), 1041-1052.
20. Jia, Y., Lu, F., Zeng, G., Sun, X., Xiao, Y., Lu, L., . . . Li, C. (2008). Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: Community-based surveys along major drug trafficking routes. Harm Reduct J, 5, 29.
21. Jia, Y., Sun, J., Fan, L., Song, D., Tian, S., Yang, Y., . . . Zhang, S. (2008) Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. Int J Epidemiol, 37(6), 1287-1296.
22. Liu, J. B.. (2007). Cox regression analysis of retention time and factors of methadone maintenance treatment Chin J AIDS STD, 13(2), 160-161.
23. Liu J. B., Zhang, L. L., Lai,W. H., Feng, L., Zeng, Y. L., Liu, L., . . . Xiao, Y. (2009). Sharing of needles and paraphernalia injection in new and long-term injection drug users in Sichuan, China. Zhonghua Liu Xing Bing Xue Za Zhi, 30(7), 656-662.
24. MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., . . . Hickman M. (2012). Opiate substitution treatment andHIV transmission in peoplewho inject drugs: Systematic review and meta-analysis. BMJ, 345, e5945.
25. Mao, W., Zhang, L., Xiao, Y., Jiang, B., Zhu, J., Ma, W., . . . Jia, Y. (2010). Barriers and facilitators to voluntaryHIV counseling and testing among injection drug users and their attitudes toward the peer opinion leader-led HIV testing through diffusion of positive AIDS care messages. Journal of Shandong University (Medical Science Edition), 48(1), 146-150.
26. Marks, G., Crepaz, N., Senterfitt, J. W., & Janssen, R. S. (2005). Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. J Acquir Immune Defic Syndr, 39(4), 446-453.
27. Metzger, D. S.,Woody, G. E.,McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., . . . Abrutyn E. (1993). Human immunodeficiency virus seroconversion among intravenous drug users inand out-of-treatment: An 18-month prospective follow-up. J Acquir Immune Defic Syndr, 6(9), 1049-1056.
28. Ministry of Health of China. (2006). Work Plan of Community Maintenance Treatment for Opioid Addicts.
29. Moatti, J. P., Carrieri, M. P., Spire, B., Gastaut, J. A., Cassuto, J. P., & Moreau J. (2000). Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS, 14(2), 151-155.
30. Montaner, J. S., Lima, V. D., Barrios, R., Yip, B.,Wood, E., Kerr, T.,, . . . Daly, P. (2010). Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada:Apopulation-based study. Lancet, 376(9740), 532-539.
31. Moss, A. R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., & Osmond, D.. (1994). HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS, 8(2), 223-231.
32. National Working Group on Community-based Methadone Maintenance Treatment for Opium Dependents. (2010). Report on Implementation of Community-based Methadone Maintenance Treatment. Guiyang: National Conference on Experience in Community-based Methadone Maintenance Treatment for Opium Dependents. .
33. Palepu, A., Tyndall, M. W., Joy, R., Kerr, T., Wood, E., Press, N., . . . Montaner, J. S. (2006). Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug Alcohol Depend, 84(2), 188-194.
34. Rhodes, T., Ball, A., Stimson, G. V., Kobyshcha, Y., Fitch, C., Pokrovsky,V., . . . Andrushchak L. (1999).HIV infection associated with drug injecting in the newly independent states, eastern Europe: The social and economic context of epidemics. Addiction, 94(9), 1323-1336.
35. Serpelloni, G., Carrieri, M. P., Rezza, G.,Morganti, S., Gomma,M., & Binkin N. (1994). Methadone treatment as a determinant of HIV risk reduction among injecting drug users: A nested casecontrol study. AIDS Care, 6(2), 215-220.
36. Shi, S., Huang, Y. S., & Li X. (2008). Correlation factors influencing the effect of methadone maintenance treatment. Chin J Drug Depend, 17(1), 56-60.
37. Sichuna Provincial CDC. (2009). HIV/AIDS Surveillance Report. Chengdu: Institute for AIDS/STD Control and Prevention.
38. Spire, B., Lucas, G. M., & Carrieri, M. P. (2007). Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy, 18(4), 262-270.
39. State Council of P.R. of China. (2012). China's Action Plan for Reducing and Preventing the Spread of HIV/AIDS (2011- 2015).
40. Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, CA. (2010). HIV and risk environment for injecting drug users: The past, present, and future. Lancet, 376(9737), 268-284.
41. Sullivan, S. G., & Wu, Z. (2007). Rapid scale up of harm reduction in China. Int J Drug Policy, 18(2), 118-128.
42. Vermund, S. H., & Wilson, C. M. (2002). Barriers to HIV testing-where next? Lancet, 360(9341), 1186-1187.
43. Wang, J, Li, F, Mo, LR, Li, L, Guan, Y, Hao, C, . . . Ruan, Y. (2007). Factors associated with retention in a communitybased methadone maintenance treatment among drug users in Urumqi,Xinjiang Uigur Autonomous Region. Chin J Epidemiol, 28(1), 37-41.
44. Williams, A. B., McNelly, E. A., Williams, A. E., & D'Aquila, R. T. (1992). Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users. AIDS Care, 4(1), 35-41.
45. Wu, Z., Luo,W., Sullivan, S. G., Rou, K., Lin, P., Liu,W.,&Ming Z. (2007). Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. AIDS, 21 Suppl 8, S115-122.
46. Wu, Z., Sun, X., Sullivan, S. G., & Detels, R. (2006). Public health. HIV testing in China. Science (New York, NY, 312(5779), 1475-1476.
47. Wu, Z., Sullivan, S. G.,Wang, Y., Rotheram-Borus, M. J., & Detels, R. (2007). Evolution of China's response to HIV/AIDS. Lancet, 369(9562), 679-690.
48. Zhang, L., Gray, R. T., &Wilson, D. P. Modelling the epidemiological impact of scaling up HIV testing and antiretroviral treatment in China. Sexual health, 9(3), 261-271.
49. Zhang, L., Li, J., Lai, W., Feng, L., Zeng, Y., Liu, L., . . . Wu, P. (2010). Prevalence and correlates of needle-sharing among new and long-term injection drug users in southwest China. Subst Use Misuse, 45(14), 2503-2523.
50. Zhang, L., Li, J., Lai, W., Feng, L., Zeng, Y., Liu, L., . . . Wu, P. (2011). Prevalence and correlates of needle-sharing among new and long-term injection drug users in southwest China. Subst Use Misuse, 45(14), 2503-2523.